Corporate Profile / Organizational Chart / History

Corporate Profile

Organization Chart

History

Corporate Profile

Summit Pharmaceuticals International Corporation

November 21, 1949

480 million yen (wholly-owned subsidiary of Sumitomo Corporation)

Katsuya Okuyama, President & CEO Masahito Uno, Director Masato Higashikawa, Director Hiroshi Yamamoto, Auditor Takeshi Nishimura, Auditor

160 (as of December 2024)

Sumitomo Mitsui Banking Corporation

45.9 billion yen (fiscal year ended March 2024)

Import, export, and marketing of drugs, quasi-drugs, medical devices, and food additives, as well as materials, bulks, and final products thereof
Import and marketing of microbial, plant and animal cells and tissues and analytical devices as drug discovery support tools, as well as brokerage and mediation of related biological services
Consulting and mediation services concerning pharmaceutical development and new drug licensing

Sumitomo Corporation Takebashi BLD. 12F 1-2-2, Hitotsubashi, Chiyoda-ku, Tokyo 100-0003 TEL : +81-(0)3-5220-1500, FAX : +81-(0)3-5220-1501

- Click here for a map of the Head Office

Sumitomo Main Bldg. 7F 4-5-33 Kitahama, Chuo-ku, Osaka City, Osaka 541-0041 TEL : +81-(0)6-6222-3971, FAX : +81-(0)6-6222-6770

- Click here for a map of the Osaka Office

135 Yokohama Bio Industry Center 1-6 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045 TEL : +81-(0)45-508-2171, FAX : +81-(0)45-508-2710

- Click here for a map of the Yokohama Support Center

R&D D437 Kanagawa Science Park 3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa 213-0012 TEL : +81-(0)44-829-1170, FAX : +81-(0)44-844-0371

- Click here for a map of the API Laboratory

2021
Expanded the API Laboratory
2021
Acquired 100% shares of Summit Pharmaceuticals China
2020
Acquired 100% shares of Summit Pharmaceuticals Europe
2011
Changed the name of the Yokohama Laboratory to the Yokohama Support Center
2009
Established the API Laboratory in Takatsu-ku, Kawasaki City
2006
Summit Medi-Chem merged with Summit Pharmaceuticals International Corporation and inherited its name

2003
Became a wholly owned business investment company of SC
2003
Changed the company name to Summit Medi-Chem
1993
SC invested in Goei Shoji
1949
Goei Shoji was established Started selling industrial chemicals and medical products

2006
Took over business rights concerning marketing and development of physicochemical devices from SC Bioscience Corporation Established the Yokohama Laboratory in Tsurumi-ku, Yokohama City
1995
Took over the business rights and assets from the New Drugs and Bioscience Department of SC and changed the company name to Summit Pharmaceuticals International Corporation
1985
Sumisho Pharma Corporation was established as a wholly-owned business investment company of Sumitomo Corporation (SC) Started supporting the New Drugs and Bioscience Department of SC, engaged in drug discovery research support, pharmaceuticals and diagnostics licensing, and other supportive activities